[18F]FDG PET/CT advanced imaging in crucial management steps of a child affected by hypoplastic left heart syndrome

Eur J Nucl Med Mol Imaging. 2023 Sep;50(11):3475-3476. doi: 10.1007/s00259-023-06264-7. Epub 2023 May 13.

Authors

Milena Pizzoferro¹, Marco Alfonso Perrone², Saadi Sollaku³, Emanuele Casciani³, Claudio Altini⁴, Maria Felicia Villani⁴, Aurelio Secinaro⁵, Maria Carmen Garganese⁴

Affiliations

¹ Nuclear Medicine Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. milena.pizzoferro@opbg.net.
² Cardiology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
³ Nuclear Medicine Section, Pio XI Private Hospital, Rome, Italy.
⁴ Nuclear Medicine Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
⁵ Cardiovascular Radiology Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

PMID: 37178353
DOI: 10.1007/s00259-023-06264-7

No abstract available

MeSH terms

Child
Fluorodeoxyglucose F18
Humans
Hypoplastic Left Heart Syndrome* / diagnostic imaging
Positron Emission Tomography Computed Tomography* / methods
Positron-Emission Tomography
Radiopharmaceuticals

Substances

Fluorodeoxyglucose F18
Radiopharmaceuticals

Grants and funding

Current Research funds/Ministero della Salute